HCV RNA DETECTION BY REAL TIME PCR (QUALITATIVE)

The HCV RNA Detection by Real‑Time PCR (Qualitative) test detects the presence or absence of hepatitis C virus (HCV) genetic material in a blood sample using sensitive real‑time polymerase chain reaction technology. Rather than providing a numeric viral load, this qualitative assay reports whether HCV RNA is "Detected" or "Not Detected," making it a definitive test for active HCV infection and early viremia detection during the antibody window period.

This test is most useful to confirm active infection after a positive HCV antibody result, evaluate recent exposure to HCV, or verify viral clearance after treatment. At‑home collection in Dubai is performed by certified phlebotomists, providing a convenient, reliable sample for laboratories accredited to UAE standards; note that quantitative PCR is required if precise viral load monitoring is needed for treatment decisions.

• HCV RNA (Qualitative)
• Detection result: Detected / Not Detected
• Method: Real‑Time PCR
• Specimen type: Plasma (EDTA) / Venous whole blood
• Reporting format: Qualitative diagnostic result

• After a positive HCV antibody screening to confirm active infection
• Following recent potential exposure to hepatitis C (needlestick, transfusion, high‑risk behaviour)
• When liver function tests (ALT/AST) are persistently elevated without known cause
• Before initiating immunosuppressive therapy, chemotherapy, or organ transplantation
• To confirm viral clearance (undetectable RNA) after completion of antiviral treatment

• Definitive confirmation of active HCV infection (presence of viral RNA)
• High sensitivity for early detection during the antibody window period
• Convenient at‑home venous collection by certified phlebotomists across Dubai
• Fast, laboratory‑grade results compatible with UAE clinical records and treatment pathways
• Reduces need for clinic visits and accelerates linkage to care if positive

• At‑home venous blood collection by a certified phlebotomist (EDTA tube/plasma)
• No fasting required; normal medications may be continued unless instructed otherwise
• Inform the collector/clinician of current or recent antiviral therapy for HCV
• Ensure availability of valid ID and Emirates contact details for electronic reporting